← Browse by Condition
Medical Condition

myeloproliferative syndrome

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for myeloproliferative syndrome sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2
1
Top Sponsors
University Hospital, Clermont-Ferrand 1 trial
Dana-Farber Cancer Institute 1 trial
NCT04935684 Phase 2
Recruiting

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

Enrollment
150 pts
Location
France
Sponsor
University Hospital, Clermont-...
View Trial →
NCT04968834
Recruiting

Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy

Enrollment
300 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology